Medtronic Forecast, price target & analysts
Medtronic Target price 2025 - Analyst rating & recommendation
Medtronic Classifications & Recommendation:
Medtronic Price Target
| Target Price | $94.83 |
| Price | $87.94 |
| Potential |
7.83%
register free of charge
|
| Number of Estimates | 23 |
|
23 Analysts have issued a price target Medtronic 2026 .
The average Medtronic target price is $94.83.
This is
7.83%
register free of charge
$109.00
23.95%
register free of charge
$85.00
3.34%
register free of charge
|
|
| A rating was issued by 33 analysts: 14 Analysts recommend Medtronic to buy, 17 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Medtronic stock has an average upside potential 2026 of
7.83%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Apr '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 32.36 | 33.50 |
| 3.64% | 3.50% | |
| EBITDA Margin | 25.89% | 28.93% |
| 1.50% | 11.74% | |
| Net Margin | 10.94% | 15.61% |
| 5.57% | 42.64% |
27 Analysts have issued a sales forecast Medtronic 2025 . The average Medtronic sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an Medtronic EBITDA forecast 2025. The average Medtronic EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 Medtronic Analysts have issued a net profit forecast 2025. The average Medtronic net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Apr '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 2.76 | 4.07 |
| 2.13% | 47.46% | |
| P/E | 21.59 | |
| EV/Sales | 3.93 |
11 Analysts have issued a Medtronic forecast for earnings per share. The average Medtronic <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Medtronic stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Current Medtronic Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham | Hold ➜ Hold | Unchanged | Feb 19 2025 |
| Baird | Neutral ➜ Neutral | Unchanged | Feb 19 2025 |
| RBC Capital | Outperform ➜ Outperform | Unchanged | Feb 19 2025 |
| UBS | Neutral ➜ Neutral | Unchanged | Feb 19 2025 |
| Needham | Hold ➜ Hold | Unchanged | Feb 12 2025 |
| Truist Securities | Hold ➜ Hold | Unchanged | Dec 18 2024 |
| Barclays | Overweight ➜ Overweight | Unchanged | Nov 26 2024 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Needham: Hold ➜ Hold
|
Feb 19 2025 |
|
Unchanged
Baird: Neutral ➜ Neutral
|
Feb 19 2025 |
|
Unchanged
RBC Capital: Outperform ➜ Outperform
|
Feb 19 2025 |
|
Unchanged
UBS: Neutral ➜ Neutral
|
Feb 19 2025 |
|
Unchanged
Needham: Hold ➜ Hold
|
Feb 12 2025 |
|
Unchanged
Truist Securities: Hold ➜ Hold
|
Dec 18 2024 |
|
Unchanged
Barclays: Overweight ➜ Overweight
|
Nov 26 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
